| 0 (0%) | 09-27 09:29 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term |  |
|||
| Targets | 6-month : | 1.57 | 1-year : | 1.67 |
| Resists | First : | 1.34 | Second : | 1.42 |
| Pivot price | 1.25  |
|||
| Supports | First : | 1.22 | Second : | 1.01 |
| MAs | MA(5) : | 1.26 | MA(20) : | 1.26 |
| MA(100) : | 1.32 |
MA(250) : | 1.6 |
|
| MACD | MACD : | -0.1 |
Signal : | -0.1 |
| %K %D | K(14,3) : | 29.2 |
D(3) : | 26.4 |
| RSI | RSI(14): 48.7 |
|||
| 52-week | High : | 2.54 | Low : | 1.12 |
Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.[ MNOV ] has closed below upper band by 28.5%. Bollinger Bands are 56.4% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 1 bars. This is a sign that the market may be about to initiate a new trend.
| If tomorrow: | Open lower | Open higher |
| High: | 1.27 - 1.28 | 1.28 - 1.29 |
| Low: | 1.21 - 1.22 | 1.22 - 1.23 |
| Close: | 1.26 - 1.27 | 1.27 - 1.28 |
Wed, 24 Sep 2025
StockNews.com Begins Coverage on MediciNova (NASDAQ:MNOV) - 富途牛牛
Mon, 22 Sep 2025
MediciNova (MNOV) Maintains "Buy" Rating from D. Boral Capital | - GuruFocus
Mon, 22 Sep 2025
MediciNova (MNOV) Completes Enrollment for Key ALS Treatment Tri - GuruFocus
Mon, 22 Sep 2025
MediciNova Announces Completion of Patient Enrollment - GlobeNewswire
Mon, 22 Sep 2025
234 ALS Patients Enrolled: MediciNova's Fast-Track Drug Trial Could Offer New Hope for Fatal Disease - Stock Titan
Sat, 20 Sep 2025
Quarterly Earnings: Can MNOV sustain earnings growth - Entry Point & Expert Curated Trade Ideas - خودرو بانک
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
|
|
|
Sector:
|
|
|
Industry:
|
|
| Shares Out | 0 (M) |
| Shares Float | 49 (M) |
| Held by Insiders | 4.208e+007 (%) |
| Held by Institutions | 2.9 (%) |
| Shares Short | 121 (K) |
| Shares Short P.Month | 0 (K) |
| EPS | -1.328e+007 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 0 |
| Profit Margin | 0 % |
| Operating Margin | -2 % |
| Return on Assets (ttm) | 679.8 % |
| Return on Equity (ttm) | -15.1 % |
| Qtrly Rev. Growth | 134600 % |
| Gross Profit (p.s.) | 0 |
| Sales Per Share | -52.7 |
| EBITDA (p.s.) | 42441.9 |
| Qtrly Earnings Growth | -0.3 % |
| Operating Cash Flow | 0 (M) |
| Levered Free Cash Flow | -10 (M) |
| PE Ratio | -0.01 |
| PEG Ratio | 0 |
| Price to Book value | 0 |
| Price to Sales | -0.03 |
| Price to Cash Flow | 0.57 |
| Dividend | 0 |
| Forward Dividend | 148130 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|